Biodesix

  • Home
  • Contact us
  • Investors
  • Terms & Conditions
  • Careers
  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
  • Technology
    • Overview
    • ProTS in Depth
    • Technical Papers
  • Products
    • Overview
    • VeriStrat
    • CLIA Laboratory
  • Companion Dx
    • Overview
    • Bio/Pharma Collaboration
    • Case Study
  • Collaboration
    • Overview
    • Clinical Investigators
    • Academic Collaboration
    • Clinical Papers
  • News
    • Press Releases
    • In the News
    • Events
    • Press Releases
    • In the News
    • Events

    Archives

    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
  • Data

    • Clinical Publications
    • Technical Publications
  • October 13th, 2011
    Biodesix to Work with Concentra and Hooper Holmes to Expand Access to VeriStrat®
    September 27th, 2011
    Biodesix Selected to Present at Multi-State Investor and Partnering Conference
    July 14th, 2011
    Biodesix Closes Series D Financing
    May 6th, 2011
    Biodesix Supports Unique Lung Cancer Research Initiative – CASTLE study enrolls initial subjects
    April 12th, 2011
    Biodesix Issued Four Additional U.S. Patents for Blood-based Oncology Tests
    March 1st, 2011
    Biodesix Receives Certification from NY State
    January 7th, 2011
    Biodesix to Present at 2011 Biotech Showcase
    November 19th, 2010
    VeriStrat® Test Identifies Lung Cancer Patients Benefiting from Combination Therapy
    November 5th, 2010
    Biodesix Completes Series C Financing and Receives Grant
    June 23rd, 2010
    Biodesix Selected as a Colorado Company to Watch
    « Older Entries
    Newer Entries »

    Copyright 2010 Biodesix, All rights reserved